New board member brings clinical expertise and IT leadership Culver City, CA – March 12, 2020: NantHealth, Inc. (NASDAQ: NH), a...
Q4 Financial Highlights 2019 vs 2018: Total revenue was $24.2 million, up 6% SaaS revenue was $18.4 million, up 6%...
Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex Culver City,...
NantHealth Chairman and CEO Will Reveal How Advancements in AI and Machine Learning are Improving the Diagnosis and Treatment of...
Culver City, Calif. – February 24, 2020: NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that...
While the practice of healthcare continues to make advances in patient care with new research, procedures, and drug therapies, the...
Study Published In Breast Cancer Research Shows How Deep-Learning Of Over 650 Breast Cancer Digital Pathology Images And Omics Data...
Findings Presented at the ASCO-SITC 2020 Clinical Immuno-Oncology Symposium Orlando, FL and Culver City, CA – February 19, 2020 –...
Culver City, CA – February 4, 2020: NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare technology company, today announced it...
Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers Burlingame, CA...
New Partnership to Enable Cost Savings and Rapid ROI Across the Continuum of Care Wheeling, WV & Culver City, CA –...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....